INNO-GENE SA ZY -10 (F:WQ3) — Market Cap & Net Worth
Market Cap & Net Worth: INNO-GENE SA ZY -10 (WQ3)
INNO-GENE SA ZY -10 (F:WQ3) has a market capitalization of $14.88 Million (€12.73 Million) as of June 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #26046 globally and #2248 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INNO-GENE SA ZY -10's stock price €0.38 by its total outstanding shares 33581081 (33.58 Million). Review WQ3 total debt and obligations to assess the company's total debt and financial obligations.
INNO-GENE SA ZY -10 Market Cap History: 2021 to 2026
INNO-GENE SA ZY -10's market capitalization history from 2021 to 2026. Data shows change from $175.18 Million to $14.88 Million (-38.17% CAGR).
INNO-GENE SA ZY -10 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INNO-GENE SA ZY -10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.71x
INNO-GENE SA ZY -10's market cap is 4.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
824.93x
INNO-GENE SA ZY -10's market cap is 824.93 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $175.18 Million | $29.95 Million | $6.03 Million | 5.85x | 29.05x |
| 2022 | $48.29 Million | $16.44 Million | $315.00K | 2.94x | 153.30x |
| 2023 | $17.67 Million | $1.13 Million | -$6.22 Million | 15.66x | N/A |
| 2024 | $15.55 Million | $3.30 Million | $18.85K | 4.71x | 824.93x |
Competitor Companies of WQ3 by Market Capitalization
Companies near INNO-GENE SA ZY -10 in the global market cap rankings as of June 18, 2026.
Key companies related to INNO-GENE SA ZY -10 by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #94 globally with a market cap of $210.18 Billion USD.
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #240 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Air Liquide SA (PA:AI): Ranked #249 globally with a market cap of $101.06 Billion USD ( €86.44 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #344 globally with a market cap of $77.79 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #94 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $515.85 |
| #240 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #249 | Air Liquide SA | PA:AI | $101.06 Billion | €166.90 |
| #344 | Sherwin-Williams Co | NYSE:SHW | $77.79 Billion | $313.80 |
INNO-GENE SA ZY -10 Historical Marketcap From 2021 to 2026
Between 2021 and today, INNO-GENE SA ZY -10's market cap moved from $175.18 Million to $ 14.88 Million, with a yearly change of -38.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €14.88 Million | 0.00% |
| 2025 | €14.88 Million | -4.29% |
| 2024 | €15.55 Million | -12.00% |
| 2023 | €17.67 Million | -63.41% |
| 2022 | €48.29 Million | -72.43% |
| 2021 | €175.18 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of INNO-GENE SA ZY -10 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.88 Million USD |
| MoneyControl | $14.88 Million USD |
| MarketWatch | $14.88 Million USD |
| marketcap.company | $14.88 Million USD |
| Reuters | $14.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About INNO-GENE SA ZY -10
HyEnergy S.A. provides genetic diagnostic solutions in Poland. The company also develops and implements diagnostic algorithm for prevention and personalization of treatment of solid tumors. In addition, it provides DNA analysis and genetic diseases diagnostic service based on NGS technology. HyEnergy S.A. was formerly known as Inno-Gene S.A. and changed its name to HyEnergy S.A. in October 2024. … Read more